Crewe Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.6K | Sell |
164
-39
| -19% | -$4.19K | ﹤0.01% | 389 |
|
2025
Q1 | $20.5K | Buy |
203
+55
| +37% | +$5.55K | ﹤0.01% | 349 |
|
2024
Q4 | $13.2K | Buy |
148
+36
| +32% | +$3.22K | ﹤0.01% | 403 |
|
2024
Q3 | $9.39K | Buy |
112
+18
| +19% | +$1.51K | ﹤0.01% | 504 |
|
2024
Q2 | $7.24K | Sell |
94
-148
| -61% | -$11.4K | ﹤0.01% | 738 |
|
2024
Q1 | $16.6K | Buy |
+242
| New | +$16.6K | ﹤0.01% | 520 |
|
2023
Q4 | – | Sell |
-7
| Closed | -$370 | – | 452 |
|
2023
Q3 | $370 | Hold |
7
| – | – | ﹤0.01% | 407 |
|
2023
Q2 | $379 | Sell |
7
-422
| -98% | -$22.8K | ﹤0.01% | 656 |
|
2023
Q1 | $21.5K | Sell |
429
-134
| -24% | -$6.7K | ﹤0.01% | 418 |
|
2022
Q4 | $26.1K | Sell |
563
-301
| -35% | -$13.9K | ﹤0.01% | 379 |
|
2022
Q3 | $33K | Buy |
864
+141
| +20% | +$5.39K | 0.01% | 371 |
|
2022
Q2 | $27K | Buy |
+723
| New | +$27K | 0.01% | 368 |
|
2020
Q4 | – | Sell |
-65
| Closed | -$2K | – | 472 |
|
2020
Q3 | $2K | Buy |
+65
| New | +$2K | ﹤0.01% | 479 |
|
2020
Q1 | – | Sell |
-73
| Closed | -$3K | – | 187 |
|
2019
Q4 | $3K | Buy |
+73
| New | +$3K | ﹤0.01% | 211 |
|